Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial

RATIONALE: Most studies evaluating the safety and tolerability of intranasal oxytocin (OT) have not reported consistent adverse events (AEs), but they have largely focused on young men and single-dose administration. Thus, it is unclear whether these findings translate to older individuals and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rung, Jillian M., Horta, Marilyn, Tammi, Erin M., Perez, Eliany, Ojeda, Marite C., Lin, Tian, Harris, Griffin, Somerville, Jessie, Salmeron, Dinia, Beltz, Susan E., Sandesara, Bhanuprasad, Feifel, David, Ebner, Natalie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115997/
https://www.ncbi.nlm.nih.gov/pubmed/33982141
http://dx.doi.org/10.1007/s00213-021-05862-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115997/
https://www.ncbi.nlm.nih.gov/pubmed/33982141
http://dx.doi.org/10.1007/s00213-021-05862-3

Ejemplares similares